825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Director Retirement - Jacks Lee Steps Down from Vaxcyte Board
Vaxcyte, Inc. Annual Meeting Results - Directors Elected
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Vaxcyte Enters $500 Million Sales Agreement with Leerink Partners
Vaxcyte Enters Underwriting Agreement for $550 Million Stock Offering
Vaxcyte, Inc. Amends Executive Change in Control Agreements
FY 2024
Q3
Q2
Q1
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence